Glucosylsphingosine is a key biomarker of Gaucher disease-Reference-Cited by-同舟云学术

Glucosylsphingosine is a key biomarker of Gaucher disease

Published:2016-08-08 Issue:11 Volume:91 Page:1082-1089
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Murugesan Vagishwari¹,Chuang Wei-Lien²,Liu Jun¹,Lischuk Andrew³,Kacena Katherine⁴,Lin Haiqun⁵,Pastores Gregory M.⁶,Yang Ruhua¹,Keutzer Joan²,Zhang Kate²,Mistry Pramod K.⁷

Affiliation:

1. Department of Internal Medicine; Yale University School of Medicine; New Haven Connecticut

2. Sanofi Genzyme; Framingham Massachusetts

3. Department of Radiology; Yale University School of Medicine; New Haven Connecticut

4. Kacena Consulting; Natick Massachusetts

5. Department of Biostatistics; Yale School of Public Health

6. Department of Neurology; New York University School of Medicine; New York

7. Department of Internal Medicine & Pediatrics; Yale University School of Medicine; New Haven Connecticut

Funder

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Genzyme

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.24491/fullpdf

Reference42 articles.

1. Understanding the natural history of Gaucher disease;Mistry;Am J Hematol,2015

2. The cellular pathology of lysosomal diseases;Cox;J Pathol,2012

3. Mutations in Jewish patients with Gaucher disease;Beutler;Blood,1992

4. Gaucher disease mutations in non-Jewish patients;Beutler;Br J Haematol,1993

5. Phenotype, diagnosis, and treatment of Gaucher's disease;Grabowski;Lancet (London, England),2008

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A 6‐month randomized controlled trial for vitamin E supplementation in pediatric patients with Gaucher disease: Effect on oxidative stress, disease severity and hepatic complications;Journal of Inherited Metabolic Disease;2024-08-25

2. Gaucher disease provides a unique window into Parkinson disease pathogenesis;Nature Reviews Neurology;2024-08-06

3. Intrinsic link between PGRN and Gba1 D409V mutation dosage in potentiating Gaucher disease;Human Molecular Genetics;2024-08-05

4. Lung Diseases and Rare Disorders: Is It a Lysosomal Storage Disease? Differential Diagnosis, Pathogenetic Mechanisms and Management;Children;2024-05-30

5. Neuronopathic Gaucher disease: Rare in the West, common in the East;Journal of Inherited Metabolic Disease;2024-05-20